TERAZOSIN HYDROCHLORIDE 5 mg Capsule, 100-count
by Apnar Pharma LP · 100 CAPSULE in 1 BOTTLE (24689-003-01)
NDC 24689-0003-01
🏷️ FDA NDC (as labeled)
24689-003-01
billing pads the product segment with a zero
This package
Contains100-count
Pack sizes2 compare ↓
Also comes in:
1000 capsules 24689-0003-10
Rx only
Generic
On market
Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
24689-003-01
Product NDC
24689-003
11-digit billing NDC
24689000301
UNII
D32S14F082
Application #
ANDA074823
SPL Set ID
619dd5cb-46fb-4ad9-a05f-f064261a636b
Established class (EPC)
alpha-Adrenergic Blocker
Mechanism of action
Adrenergic alpha-Antagonists
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2026-08-07
Route
ORAL
Dosage form
CAPSULE
Substance
TERAZOSIN HYDROCHLORIDE
TE code (Orange Book)
AB · RLD · RS
Why two NDCs?
The FDA registers this code as 24689-003-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 24689-0003-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the alpha-Adrenergic Blocker class.
Pharmacologic class
alpha-Adrenergic Blocker
Drug family (ATC)
Alpha-adrenoreceptor antagonists
How it works
Adrenergic alpha-Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerApnar Pharma LP
Application holderSENORES PHARMACEUTICALS INC
FDA applicationANDA074823 (ANDA)
Labeler code24689
First marketedAug 2026
Product typeHuman Prescription Drug
Portfolio28 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- It can actually be used for both. Terazosin relaxes smooth muscle in the prostate and bladder neck, which helps urine flow more easily if you have an enlarged prostate (BPH). That...
- What exactly does terazosin do — is it for my prostate or my blood pressure?
- The first dose — and doses after any break or increase — can cause a significant drop in blood pressure, especially when you stand up. That can make you dizzy or even faint. Taking...
- Why do I have to take the first dose at bedtime? Can't I just take it in the morning?
Patient education
Supplement & herbal interactions
1
Nutrient depletion considerations
Terazosin may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about terazosin hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
White / Yellow / Pink / Turquoise
ShapeCapsule
ImprintAP784
Size16 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
1000 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Terazosin 5 mg 59746-0385-06 | Jubilant | 100 capsules | $0.108 | AB | Availability likely | — |
| Terazosin 5 mg 50268-0766-15 | AvPAK | 50 capsules | $0.108 | AB | Availability likely | — |
| Terazosin 5 mg 63187-0456-90 | Proficient | 90 capsules | — | AB | FDA listed | — |
| Terazosin 5 mg 71610-0503-60 | Aphena | 90 capsules | — | AB | FDA listed | — |
| Terazosin Hydrochloride 5 mg 71610-0595-60 | Aphena | 90 capsules | — | AB | FDA listed | — |
| Terazosin 5 mg 50090-1559-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| Terazosin 5 mg 70518-0317-00 | REMEDYREPACK | 30 capsules | — | AB | FDA listed | — |
| Terazosin Hydrochloride 5 mg 63629-1414-01 | Bryant | 100 capsules | — | AB | FDA listed | — |
| Terazosin 5 mg 42291-0822-10 | AvKARE | 1000 capsules | — | AB | FDA listed | — |
| Terazosin hydrochloride 5 mg 68788-9815-01 | Preferred | 100 capsules | — | AB | FDA listed | — |
| Terazosin Hydrochloride 5 mg 69292-0203-01 | Amici | 100 capsules | — | AB | FDA listed | — |
| Terazosin 5 mg 72162-2183-00 | Bryant | 1000 capsules | — | AB | FDA listed | — |
| Terazosin 5 mg 67046-1622-03 | Coupler | 30 capsules | — | AB | FDA listed | — |
| Terazosin 5 mg 71610-0786-60 | Aphena | 90 capsules | — | AB | FDA listed | — |
| Terazosin Hydrochloride 5 mg 87564-0008-01 | Amerisyn, | 1000 capsules | — | AB | FDA listed | — |
| Terazosin Hydrochloride 5 mgthis 24689-0003-01 | Apnar | 100 capsules | — | AB | FDA listed | — |
| Terazosin Hydrochloride 5 mg 87564-0083-01 | Amerisyn | 1000 capsules | — | AB | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2026
On the market since
Aug 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Terazosin Hydrochloride — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 85%
Female · 15%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 24689-0003-01 You're viewing this | 100 CAPSULE in 1 BOTTLE (24689-003-01) | 2026-08-07 | Active |
| 24689-0003-10 | 1000 CAPSULE in 1 BOTTLE (24689-003-10) | 2026-08-07 | Active |
You're viewing the smallest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 24689-0003-01?
NDC 24689-0003-01 is a 100-count package — 100 capsule in 1 bottle.
What is the difference between NDC 24689-0003-01 and NDC 24689-0003-10?
Both are TERAZOSIN HYDROCHLORIDE 5 mg Capsule — the drug itself is identical. NDC 24689-0003-01 is the 100-count package, while NDC 24689-0003-10 is the 1000 capsules package.
What NDC number is used to bill for this package of TERAZOSIN HYDROCHLORIDE 5 mg Capsule?
Bill NDC 24689-0003-01 — the 11-digit billing format is 24689000301. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 24689-003-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 24689-0003-01, written without dashes as 24689000301. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 24689-0003-01, the first segment (24689) is the labeler code FDA assigned to Apnar Pharma LP; the middle segment (0003) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Apnar Pharma LP. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1000 capsules (24689-0003-10). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Apnar Pharma LP is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No readable label sections were found for this product.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.